People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| TripActions, Inc. | — | Other Technology | Series D+ | $1.0B | $6.3B | 2021 |
| Sonoma Biotherapeutics, Inc. | — | Biotechnology | Series D+ | $265.0M | $7.7B | 2021 |
Maggie Wilderotter at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Maggie Wilderotter on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ben Horowitz | 1 | 15 |
| Oren Zeev | 1 | 12 |
| Arif Janmohamed | 1 | 8 |
| Richard Klausner | 1 | 7 |
| Terry Rosen | 1 | 4 |
| Fan Yu | 1 | 4 |
| Jeffrey Bluestone | 1 | 2 |
| Ilan Twig | 1 | 2 |
| Ariel Cohen | 1 | 2 |
| Toni Hoover | 1 | 1 |
| THOMAS TUCHSCHERER | 1 | 1 |
| SAUYEH JAHANN | 1 | 1 |
| SAI JAHANN | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.